Duodopa rejected for NHS use in Scotland

News

Author: Almaz OhenePublished: 11 January 2016

Prep: Cook: Serves:

The advanced Parkinson’s treatment Duodopa has been rejected for routine use on the NHS in Scotland, sparking concerns among charities and health professionals.

The Scottish Medicines Consortium (SMC) said it was unable to approve of Duodopa, due to questions raised over its cost-effectiveness.

Dr Alan MacDonald, vice chairman of SMC, said: “The Committee was unable to accept co-careldopa intestinal gel (Duodopa) for the routine treatment of advanced Parkinson’s disease because of uncertainty about the clinical benefits the medicine would provide for this patient group in relation to its cost.”

Duodopa, which can help to control the symptoms of advanced Parkinson’s when all other treatments have stopped working. The gel treatment is administered to the intestine via pump and a tube and requires the patient to undergo surgery – it is estimated to cost around £28,000-per-year per patient and was approved for use by the NHS in England in July 2015.

Last Month

Next Month

Go Back

Share this story

Comments

Health & Fitness

EPDA ExerciseCast: How to stay active during the coronavirus crisis

Josefa Domingos on how to stay active in lockdown

Painting a picture of life with Parkinson’s

Australian artist Timothy John describes his work

How I got Damien Hirst to make art for Parkinson’s

Fifty famous contemporary artists are selling art for Parkinson’s

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

A new study reprogramming cells to replace reduced dopamine neurons in the brain could be used to reverse symptoms of Parkinson’s and other neurological conditions. As part of the study – conducted by the University of California San Diego (UCSD) – researchers found a way to convert star-shaped brain cells called astrocytes into cells producing dopamine. The team used the method to treat mouse models of Parkinson’s, administering the treatment into the areas of the brain that typically lose dopamine producing neurons. This restored reduced dopamine production to normal levels and reversed the symptoms of Parkinson’s. The researchers will continue to optimise the therapy in other mouse models of Parkinson’s before testing it on people with the condition. William Mobley, a neurosciences professor at UCSD, said: “I was stunned at what I saw. This whole new strategy for treating neurodegeneration gives hope that it may be possible to help even…

Could a magnetically powered implant treat Parkinson’s tremors?

A tiny surgical implant about the size of a grain of rice that can be implanted with minimally invasive surgery may be used to treat tremors in people with Parkinson’s. Developed by a team of researchers at Rice University, US, the implant uses a thin film of magnetoelectric material to convert acoustic waves from the brain’s magnetic field into electrical voltage. The device produces the same high-frequency signals as clinically approved implants used to treat Parkinson’s, epilepsy and other conditions – and eliminates the need for battery or wired power supply. In an initial study, the researchers showed that the implants worked in rodents. Professor Jacob Robinson, corresponding author of the study, said: “Our results suggest that using magnetoelectric materials for wireless power delivery is more than a novel idea. These materials are excellent candidates for clinical-grade, wireless bioelectronics.”

What do you think of Parkinson’s Life? Take part in our reader survey

We’re always looking to improve our readers’ experience of the Parkinson’s Life magazine, newsletter and podcast. That’s why we’ve launched a new survey to give our international community of readers a chance to share their views and influence what we do. The survey takes just 10 minutes to complete – and, as a little ‘thank you’ for taking part, readers will be entered into a competition to win a £50 Amazon voucher. Readers will also have the chance to share interest in joining our future reader panel and take part in regular surveys and discussions to help us to deliver the best content to our international community. Ready to tell us what you think of Parkinson’s Life? Take part in the reader survey here.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Comments
This field is for validation purposes and should be left unchanged.

Duodopa rejected for NHS use in Scotland

News

Author: Almaz OhenePublished: 11 January 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Health & Fitness

EPDA ExerciseCast: How to stay active during the coronavirus crisis

Perspectives

Painting a picture of life with Parkinson’s

Interviews

How I got Damien Hirst to make art for Parkinson’s

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Could a magnetically powered implant treat Parkinson’s tremors?

What do you think of Parkinson’s Life? Take part in our reader survey

{title}

Subscribe

Duodopa rejected for NHS use in Scotland

News

Author: Almaz OhenePublished: 11 January 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Health & Fitness

EPDA ExerciseCast: How to stay active during the coronavirus crisis

Perspectives

Painting a picture of life with Parkinson’s

Interviews

How I got Damien Hirst to make art for Parkinson’s

Researchers “stunned” by study that raises hopes for Parkinson’s treatment

Could a magnetically powered implant treat Parkinson’s tremors?

What do you think of Parkinson’s Life? Take part in our reader survey

{title}

Subscribe

Sign in